Purpose

We established the first Blockchain Organs Exchange in the World supported by clinical institutions

At a time of global organs scarcity, this concept is going to revolutionize solid organs transplantation worldwide, combining Blockchain with AI

The exchange is operated on a nonprofit basis and aligns the incentives of all stakeholders along the transplantation continuum by making its processes more effective, efficient, transparent, secured and trustworthy - Creating a fully virtualized and tokenized transplant ecosystem with trust at its core

We leverage advanced AI combined with transcriptomics and gene expression capabilities to enhance current clinical practice

These minimally invasive AI-piloted diagnostics are improving disease monitoring, clinical decision, and patients’ outcome

For example, our world class Cell-Free DNA AI Platform (cfDNA-AI) allows us to develop solutions in the field of Transplantation, Oncology, Cardiology or Inflammation

This platform therefore increases the ability to detect allograft injuries, multiple cancer types, autoimmune diseases or disease progression much earlier and more accurately than the standard of care through AI augmentation of recent biological and molecular testing technologies 

Our Public-Private-Partnership platform allows us to support countries in the developing world with under-invested healthcare ecosystems - particularly Africa

We partner with Healthcare Authorities (HAs) and healthcare institutions (HCOs) to set-up local or pan-countries biomedical research institutions and develop research capabilities of local Healthcare professionals (HCPs)

A small proportion of research activities are performed out of developing counties and we ought to change this. Also, a lot of diseases prevalent in these countries are not well understood, diagnosed and treated, and would benefit from advanced digital technologies to further their understanding - especially the growing burden of NCDs